Conditions: Esophageal Cancer
Intervention Type: Biological
Intervention Name: URLC10, VEGFR1 and VEGFR2
Clinical Trials
The following are clinical trials from the Healia Clinical Trials Information Database that are researching the effect of the "Biological" intervention "URLC10, VEGFR1 and VEGFR2" on "Esophageal Cancer".
-
Phase I/II Study of Multiple-Vaccine Therapy Using Epitope Peptide Restricted to HLA-A*0201 in Treating Patients With Refractory Esophageal Cancer
NCTID: NCT00681421
